---
id: openai-longevity-model
slug: openai-longevity-model
entity_type: commercial
status: operational
data_completeness: high
last_researched: 2025-01-27
researcher: AI Assistant
version: 2.1
name: OpenAI & Retro Biosciences - Stem Cell Manufacturing Optimization via Gene Regulatory Network Modeling
description: Collaboration between OpenAI and Retro Biosciences to develop transformer-based AI models that optimize gene regulatory networks for scalable stem cell manufacturing. The project focuses on using AI to identify optimal gene interaction patterns that enhance manufacturing efficiency while maintaining cell quality and identity, addressing a critical bottleneck in regenerative medicine.
mission: To extend healthy human lifespan by 10 years through the development of therapies targeting cellular mechanisms of aging, including cellular reprogramming, autophagy enhancement, and regenerative medicine. The company focuses on translating scientific discoveries into practical interventions for age-related diseases.
entity_data:
  focus: Development of therapies to extend healthy human lifespan by 10 years through cellular reprogramming, autophagy enhancement, and regenerative medicine
  founded: 2021
  website: "https://retro.bio"
  industry: Biotechnology
  employees:
  as_of: 2025
  current: 54
  legal_name: Retro Biosciences, Inc.
  headquarters:
  city: Redwood City
  state: California
  address: Redwood City, California
  country: USA
taxonomy:
  geography: USA
  ai_approach: []
  ai_technology:
  - Transformers
  primary_focus:
  - Cellular Rejuvenation
  - Omics Data Analysis
  aging_approach:
  - Cellular Rejuvenation
  target_biology:
  - General Aging/Longevity
  ai_architecture:
  - Transformers
  ai_specialization: []
  development_stage: Operational
  therapeutic_modality:
  - Cell Therapy
organizations:
  -
    name: OpenAI
    role: partner
    org_type: company
    legal_name: OpenAI, L.P.
    founded: 2015
    website: "https://www.openai.com"
    status: operational
    role_description: Research collaboration partner providing AI expertise
    contribution_description: Developed transformer-based AI model architecture and training methodology. Provided AI expertise for gene regulatory network modeling and optimization algorithms.
  -
    name: Retro Biosciences
    role: primary
    org_type: company
    legal_name: Retro Biosciences, Inc.
    founded: 2021
    website: "https://retro.bio"
    status: operational
    role_description: Primary organization developing stem cell manufacturing capabilities
    contribution_description: Provided biological expertise, manufacturing process data, and experimental validation capabilities. Translated AI recommendations into actual manufacturing improvements.
products:
  -
    name: OpenAI Longevity Model for Stem Cell Manufacturing
    type: ai_model
    status: Operational
    development_stage: Released
links:
  -
    url: "https://observer.com/2025/05/sam-altman-retro-biosciences-extend-human-age/"
    type: news_article
    title: "Sam Altman's Retro Biosciences Aims to Add a Decade to Human Life"
  -
    url: "https://www.forbes.com/sites/alexknapp/2025/01/17/the-prototype-openai-and-retro-biosciences-made-an-ai-model-for-bioengineering/"
    type: news_article
    title: "The Prototype: OpenAI And Retro Biosciences Made An AI Model For Bioengineering"
  -
    url: "https://techcrunch.com/2025/01/17/openai-is-trying-to-extend-human-life-with-help-from-a-longevity-startup/"
    type: news_article
    title: OpenAI is trying to extend human life, with help from a longevity startup
  -
    url: "https://openai.com/research"
    type: website
    title: OpenAI for Science Initiative
  -
    url: "https://openai.com/index/accelerating-life-sciences-research-with-retro-biosciences"
    type: blog_post
    title: Accelerating life sciences research
---

# OpenAI & Retro Biosciences - Stem Cell Manufacturing Optimization via Gene Regulatory Network Modeling

## Description

Collaboration between OpenAI and Retro Biosciences to develop transformer-based AI models that optimize gene regulatory networks for scalable stem cell manufacturing. The project focuses on using AI to identify optimal gene interaction patterns that enhance manufacturing efficiency while maintaining cell quality and identity, addressing a critical bottleneck in regenerative medicine.

## Mission

To extend healthy human lifespan by 10 years through the development of therapies targeting cellular mechanisms of aging, including cellular reprogramming, autophagy enhancement, and regenerative medicine. The company focuses on translating scientific discoveries into practical interventions for age-related diseases.

## Company Information

**Legal Name**: Retro Biosciences, Inc.
**Founded**: 2021
**Industry**: Biotechnology
**Employees**: {"as_of":"2025","current":54}
**Focus**: Development of therapies to extend healthy human lifespan by 10 years through cellular reprogramming, autophagy enhancement, and regenerative medicine
**Website**: https://retro.bio

## System Architecture

```yaml
data_flow:
  - 1. Multi-omic data collected from stem cell manufacturing processes
  - 2. Transformer model infers gene regulatory networks from data
  - 3. Optimization engine identifies optimal network configurations
  - 4. Recommendations provided for manufacturing process adjustments
  - 5. Manufacturing processes implement recommendations
  - 6. Outcomes measured and analyzed
  - 7. Feedback provided to AI model
  - 8. Model refines network configurations based on outcomes
  - 9. Process repeats for continuous improvement
components:
  -
    name: Transformer-based Network Inference Model
    role: Gene regulatory network inference
    function: Processes multi-omic data (transcriptomic, epigenomic) to infer regulatory relationships between genes, constructing gene regulatory network models
    capabilities:
    - Multi-omic data integration
    - Regulatory relationship inference
    - Network topology construction
    - Interaction strength estimation
  -
    name: Network Optimization Engine
    role: Network configuration optimization
    function: Optimizes gene regulatory network configurations to identify patterns that maximize manufacturing efficiency
    capabilities:
    - Network configuration search
    - Efficiency prediction
    - Quality constraint optimization
    - Multi-objective optimization
  -
    name: Manufacturing Process Interface
    role: Integration with manufacturing
    function: Connects AI model recommendations with actual stem cell manufacturing processes
    capabilities:
    - Process parameter translation
    - Recommendation implementation
    - Outcome measurement
    - Feedback collection
  -
    name: Feedback Loop
    role: Iterative improvement
    function: Transmits manufacturing outcomes back to the AI model for iterative refinement
    capabilities:
    - Outcome analysis
    - Performance metrics calculation
    - Model refinement
    - Iteration control
description: The system integrates transformer-based AI models with stem cell manufacturing processes to create a closed-loop optimization system. The AI model analyzes multi-omic data, infers gene regulatory networks, optimizes network configurations, and provides recommendations for manufacturing process improvements.
```

## Technical Workflow

```yaml
steps:
  -
    name: Data Acquisition
    step: 1
    input: Stem cell manufacturing process data
    output: Processed multi-omic datasets ready for network inference
    process: Data preprocessing, quality control, normalization
    description: Collect multi-omic datasets from stem cell manufacturing processes including transcriptomic profiles, epigenomic data, and manufacturing outcome metrics
  -
    name: Network Inference
    step: 2
    input: Processed multi-omic datasets
    output: Inferred gene regulatory network with topology and interaction strengths
    process: Transformer architecture analyzes gene expression patterns to infer regulatory relationships
    description: Transformer model processes multi-omic data to infer gene regulatory networks, identifying regulatory relationships and interaction strengths
  -
    name: Network Optimization
    step: 3
    input: Inferred gene regulatory network
    output: Optimized network configuration with predicted efficiency improvements
    process: Optimization algorithm searches network configuration space to maximize efficiency metrics while maintaining quality constraints
    description: Model optimizes network configurations to identify gene expression patterns that maximize manufacturing efficiency
  -
    name: Recommendation Generation
    step: 4
    input: Optimized network configuration
    output: Manufacturing process recommendations
    process: Configuration translated to process parameters (gene expression targets, culture conditions, timing)
    description: Model translates optimized network configurations into actionable recommendations for manufacturing process adjustments
  -
    name: Manufacturing Implementation
    step: 5
    input: Manufacturing process recommendations
    output: Stem cells produced using optimized process
    process: Process parameters adjusted according to recommendations, manufacturing executed
    description: Stem cell manufacturing processes implement AI recommendations
  -
    name: Outcome Measurement
    step: 6
    input: Stem cells from optimized process
    output: Quantified manufacturing outcomes
    process: Quality assessment, yield measurement, efficiency calculation
    description: Manufacturing outcomes measured including yield, quality metrics, and efficiency parameters
  -
    name: Feedback Integration
    step: 7
    input: Manufacturing outcomes
    output: Refined network optimization model
    process: Outcomes compared to predictions, discrepancies identified, model updated
    description: Outcomes provided to AI model as feedback for iterative refinement
  -
    name: Iterative Refinement
    step: 8
    input: Refined model and new data
    output: Continuously improving manufacturing efficiency
    process: Cycle repeats from network inference with updated model
    description: Process repeats with refined model, continuously improving manufacturing efficiency
overview: Iterative optimization workflow where transformer model infers gene regulatory networks, optimizes configurations, and refines recommendations based on manufacturing outcomes
```

## Scientific Background

```yaml
ai_approach:
  network_modeling: Network modeling allows the AI to understand and optimize the relationships between genes involved in stem cell production. The model identifies which gene expression patterns correlate with high manufacturing efficiency while maintaining cell quality.
  transformer_advantage: "Transformer-based AI models can process large-scale multi-omic datasets to infer gene regulatory networks and identify optimal configurations. Unlike traditional methods, transformers can: (1) Model complex, non-linear regulatory relationships, (2) Integrate multiple data types simultaneously, (3) Scale to large networks with thousands of genes, (4) Learn from manufacturing outcome data"
  optimization_capability: The AI can systematically explore the space of possible network configurations, identifying patterns that would be difficult or impossible to discover through manual experimentation alone.
biological_context:
  stem_cell_types: The model focuses on induced pluripotent stem cells (iPSCs), which are reprogrammed from adult cells and can differentiate into various cell types for therapeutic use.
  regulatory_control: Gene regulatory networks control each stage of manufacturing. Transcription factors and regulatory elements determine whether cells proliferate, maintain identity, or differentiate, directly impacting manufacturing efficiency and quality.
  manufacturing_process: "Stem cell manufacturing involves: (1) Cell expansion (proliferation to increase cell numbers), (2) Quality maintenance (preserving desired cell characteristics), (3) Differentiation control (maintaining or directing cell fate), (4) Harvesting and processing (preparing cells for therapeutic use)"
scalability_importance:
  ai_solution: By optimizing gene regulatory networks, the AI model enables more efficient scaling. Optimized networks can maintain cell quality and identity even as manufacturing processes are scaled to therapeutic volumes.
  current_limitations: Traditional stem cell manufacturing processes struggle to scale efficiently. Production costs increase non-linearly with scale, and quality can degrade as processes are scaled up.
  therapeutic_requirements: Regenerative medicine applications require large quantities of stem cells. For example, a single therapeutic dose may require millions to billions of cells, necessitating scalable manufacturing processes.
gene_regulatory_networks:
  complexity: Human cells contain approximately 20,000 protein-coding genes with millions of potential regulatory interactions. The complexity of these networks makes manual optimization infeasible.
  definition: Gene regulatory networks (GRNs) are systems of genes, transcription factors, and regulatory elements that control gene expression. In stem cell manufacturing, GRNs determine cell fate, differentiation state, and production efficiency.
  role_in_stem_cells: "GRNs control key processes in stem cell manufacturing: (1) Maintenance of pluripotency or desired differentiation state, (2) Cell proliferation and expansion, (3) Quality control and identity maintenance, (4) Response to culture conditions and manufacturing parameters"
stem_cell_manufacturing_challenge:
  bottleneck: "Stem cell manufacturing for regenerative medicine faces a critical bottleneck: producing sufficient quantities of high-quality cells at therapeutic scale. Traditional approaches rely on trial-and-error optimization of culture conditions, which is slow and limited in scope."
  key_challenges:
  - Optimizing gene expression patterns for maximum yield while maintaining cell quality
  - Balancing multiple competing objectives (yield, quality, scalability, cost)
  - Understanding complex gene regulatory interactions that control manufacturing outcomes
  - Scaling from laboratory to therapeutic production volumes
  traditional_limitations: Traditional experimental approaches can only test a limited number of gene expression configurations due to time and resource constraints. The search space of possible network configurations is too large for exhaustive exploration.
```

## Lessons Learned

### Achievements

- Successfully developed transformer-based model for gene regulatory network optimization
- Enabled scalable stem cell production through AI-driven optimization
- Demonstrated feasibility of using AI for complex biological manufacturing processes
- Established framework for iterative optimization of manufacturing processes using AI

### Challenges

- Complexity of gene regulatory networks requires sophisticated AI approaches capable of modeling non-linear relationships
- Multi-scale integration needed for scalable stem cell production (molecular to process level)
- Balancing optimization of multiple gene interactions simultaneously while maintaining cell quality
- Translating AI recommendations into actionable manufacturing process adjustments
- Validating AI predictions in actual manufacturing environments

### Impact on Field

This collaboration demonstrates the potential of AI, specifically transformer models, to optimize complex biological processes like stem cell manufacturing. By enabling scalable production through gene regulatory network optimization, this work advances the field of regenerative medicine. The systematic approach to network optimization addresses a critical bottleneck in therapeutic stem cell production, making regenerative medicine applications more feasible at scale. The iterative optimization framework provides a template for applying AI to other complex biological manufacturing challenges.

## Organizations

### OpenAI
**Legal Name**: OpenAI, L.P.
**Role in Project**: partner
**Role Description**: Research collaboration partner providing AI expertise
**Contribution**: Developed transformer-based AI model architecture and training methodology. Provided AI expertise for gene regulatory network modeling and optimization algorithms.
**Organization Type**: company
**Status**: operational
**Founded**: 2015
**Website**: https://www.openai.com
**Description**: AI research company specializing in large language models and AI applications for life sciences
**Focus**: Artificial Intelligence, Large Language Models, Life Sciences Research

### Retro Biosciences
**Legal Name**: Retro Biosciences, Inc.
**Role in Project**: primary
**Role Description**: Primary organization developing stem cell manufacturing capabilities
**Contribution**: Provided biological expertise, manufacturing process data, and experimental validation capabilities. Translated AI recommendations into actual manufacturing improvements.
**Organization Type**: company
**Status**: operational
**Founded**: 2021
**Website**: https://retro.bio
**Description**: Development of therapies to extend healthy human lifespan by 10 years through cellular reprogramming, autophagy enhancement, and regenerative medicine
**Focus**: Cellular reprogramming, autophagy enhancement, regenerative medicine

## Locations

### OpenAI Headquarters
**Type**: headquarters
**Address**: 3180 18th Street, San Francisco, California
**City**: San Francisco
**State/Region**: California
**Country**: USA
**Organizations**: OpenAI

### Redwood City, USA
**Type**: headquarters
**Address**: Redwood City, California
**City**: Redwood City
**State/Region**: California
**Country**: USA
**Organizations**: Retro Biosciences

## Products

### OpenAI Longevity Model for Stem Cell Manufacturing
**Alternative Names**: Stem Cell Manufacturing AI Model, Gene Regulatory Network Optimization Model
**Type**: ai_model
**Status**: Operational
**Development Stage**: Released
**Role in Project**: primary
**Relationship Description**: Core AI model developed through the collaboration for optimizing gene regulatory networks in stem cell manufacturing
**Description**: Transformer-based AI model that models and optimizes gene regulatory networks (GRNs) to identify optimal gene interaction patterns for scalable stem cell production. The model processes multi-omic data (transcriptomic, epigenomic) to infer regulatory relationships between genes, then optimizes these networks to enhance manufacturing efficiency while maintaining cell quality and identity.
**Mechanism of Action**: Transformer-based AI model that infers and optimizes gene regulatory networks for scalable stem cell production
**Target**: Gene regulatory networks controlling stem cell production, differentiation, and quality maintenance
**Pathway**: Gene regulatory network optimization for regenerative interventions
**Indications**: {
  "primary": "Stem cell manufacturing for regenerative medicine",
  "secondary": "Scalable production of induced pluripotent stem cells (iPSCs) for therapeutic applications"
}
**Technical Details**:
```yaml
method:
  - "Network Modeling: Transformer architecture processes gene expression data to infer regulatory relationships"
  - "Gene Interaction Optimization: Identifies optimal gene interaction patterns that maximize manufacturing efficiency"
  - "Multi-scale Integration: Handles interactions across molecular, cellular, and process scales"
output:
  - Optimized gene regulatory network configurations
  - Recommended gene expression patterns for enhanced manufacturing
  - Predicted manufacturing efficiency improvements
  - Quality metrics for stem cell production
input_data:
  - Multi-omic datasets (transcriptomic, epigenomic data)
  - Gene expression profiles from stem cell manufacturing processes
  - Regulatory network topology data
  - Manufacturing process parameters and outcomes
model_type: Gene regulatory network inference and optimization model
capabilities:
  - Infers gene regulatory networks from multi-omic data
  - Optimizes complex gene interactions for scalable production
  - Handles multi-scale integration complexity (molecular to process level)
  - Systematic optimization of gene networks while maintaining cell quality
  - Predicts manufacturing outcomes based on network configurations
release_date: January 2025
training_data: Multi-omic datasets from stem cell manufacturing processes, including transcriptomic and epigenomic profiles
impact_metrics:
  reduces_cost: More efficient manufacturing processes reduce resource requirements
  reduces_time: Faster stem cell production through optimized gene regulatory networks
  expands_search_space: Systematic exploration of gene network configurations beyond manual experimental capacity
  enables_qualitatively_new_experiments: Scalable stem cell production enables regenerative interventions at therapeutic scale
ai_architecture: Transformer-based neural networks
optimization_objective: Maximize stem cell production efficiency (yield, quality, scalability) while maintaining cell identity and therapeutic potential
```

## Key People

### Joe Betts-LaCroix
**Title**: Co-founder, CEO
**Participation Type**: founder
**Role in Project**: Co-founder and CEO
**Expertise**: Biotechnology, longevity research, entrepreneurship
**Biography**: Entrepreneur and biotechnology executive. Previously founded Vium (sold to Recursion) and OQO (sold to Google). Has experience in biotechnology and longevity research.
**Bio**: Co-founder and CEO of Retro Biosciences. Previously founded Vium (sold to Recursion) and OQO (sold to Google).

## Links

### [Sam Altman's Retro Biosciences Aims to Add a Decade to Human Life](https://observer.com/2025/05/sam-altman-retro-biosciences-extend-human-age/)
**Type**: news_article
**Relevance**: secondary
**Category**: publication
**Relationship Description**: Article about Retro Biosciences mission and Sam Altman's involvement
**Publication Date**: 2025-05-01
**Description**: Observer article about Retro Biosciences and its mission to extend human lifespan

### [The Prototype: OpenAI And Retro Biosciences Made An AI Model For Bioengineering](https://www.forbes.com/sites/alexknapp/2025/01/17/the-prototype-openai-and-retro-biosciences-made-an-ai-model-for-bioengineering/)
**Type**: news_article
**Relevance**: secondary
**Category**: publication
**Relationship Description**: Forbes coverage of the AI model for bioengineering
**Publication Date**: 2025-01-17
**Description**: Forbes article about OpenAI and Retro Biosciences collaboration on AI model for bioengineering

### [OpenAI is trying to extend human life, with help from a longevity startup](https://techcrunch.com/2025/01/17/openai-is-trying-to-extend-human-life-with-help-from-a-longevity-startup/)
**Type**: news_article
**Relevance**: secondary
**Category**: publication
**Relationship Description**: News coverage of the OpenAI-Retro Biosciences collaboration
**Publication Date**: 2025-01-17
**Description**: TechCrunch article about OpenAI's collaboration with Retro Biosciences on longevity research

### [OpenAI for Science Initiative](https://openai.com/research)
**Type**: website
**Relevance**: tertiary
**Category**: related
**Relationship Description**: OpenAI research initiatives including life sciences
**Publication Date**: 2025-01-01
**Description**: OpenAI's research initiatives including life sciences applications

### [Accelerating life sciences research](https://openai.com/index/accelerating-life-sciences-research-with-retro-biosciences)
**Type**: blog_post
**Relevance**: primary
**Category**: source
**Relationship Description**: Primary source: Official OpenAI blog post announcing the collaboration
**Publication Date**: 2025-08-22
**Description**: OpenAI blog post describing collaboration with Retro Biosciences on AI models for life sciences research, including the stem cell manufacturing optimization project

## Financials

### investment
**Amount**: $180 million USD
**Amount (Numeric)**: 180000000
**Funding Date**: 2022-03-01
**Source**: Sam Altman
**Funding Type**: Seed
**Description**: Initial seed funding round for Retro Biosciences
**Note**: Initial funding round led by Sam Altman
**Details**:
```yaml
year: 2022
investors:
  - Sam Altman
```

## Events

### Company Founded
**Date**: 2021-01-01
**Type**: foundation
**Description**: Retro Biosciences founded with mission to extend healthy human lifespan by 10 years

### Seed Funding
**Date**: 2022-03-01
**Type**: funding
**Description**: Raised $180 million in seed funding led by Sam Altman

### Partnership Initiated
**Date**: 2024-01-01
**Type**: partnership
**Description**: Collaboration with OpenAI initiated to develop AI models for life sciences research, focusing on gene regulatory network modeling for stem cell manufacturing

### Product Release
**Date**: 2025-01-01
**Type**: launch
**Description**: Release of OpenAI Longevity Model for stem cell manufacturing, enabling scalable stem cell production through gene regulatory network optimization. Model released as part of OpenAI's life sciences research initiative.

## Partnerships

### research
**Date**: 2024-01-01
**Focus**: Stem cell manufacturing optimization through AI-driven gene regulatory network modeling
**Description**: Collaboration to develop AI models for life sciences research, specifically focusing on gene regulatory network modeling for stem cell manufacturing. OpenAI provided transformer-based AI expertise and model development capabilities. Retro Biosciences provided biological expertise, manufacturing process data, and validation capabilities.
**Partner Organizations**:
- OpenAI (partner)
  - AI model development, transformer architecture design, training methodology provider
- Retro Biosciences (partner)
  - Biological expertise provider, manufacturing data source, experimental validation partner
**Details**:
```yaml
period: 2024-2025
outcomes:
  - Development of transformer-based AI model for gene network optimization
  - Enabled scalable stem cell production through systematic network optimization
  - Demonstrated feasibility of AI-driven optimization for complex biological manufacturing processes
collaboration_structure: OpenAI developed the AI model architecture and training methodology. Retro Biosciences provided domain expertise, manufacturing data, and experimental validation. Joint effort to integrate AI recommendations with actual manufacturing processes.
```
